Drug lookup
Drug reference

olaratumab

human IgG1 monoclonal antibody, PDGFRα inhibitor · anticancer

human IgG1 monoclonal antibody, PDGFRα inhibitoranticancer
CDSCO approved
EXCRETION
not curated
INTERACTIONS
12 major
SEVERE in our sources
PREGNANCY
not curated
Top interactionssee all 12
  • AdalimumabSevereDatabaseDDInter
  • BaricitinibSevereDatabaseDDInter
  • CertolizumabSevereDatabaseDDInter
  • CladribineSevereDatabaseDDInter

Mechanism

Olaratumab is a human IgG1 monoclonal antibody that binds to PDGFRα and blocks ligand-mediated receptor activation.

Indications

soft-tissue sarcoma (in combination with doxorubicin) for adult patients with a histological subtype for which an anthracycline-containing regimen is appropriate and which is not amenable to curative treatment with radiotherapy or surgery

Side effects

Common
nauseafatigueneutropeniamusculoskeletal painmucositisalopeciavomitingdiarrheadecreased appetiteabdominal painneuropathyheadache
Serious
  • lymphopenia
  • neutropenia
  • thrombocytopenia
  • hyperglycemia
  • elevated activated partial thromboplastin time
  • hypokalemia
  • hypophosphatemia
  • infusion-related reactions (low blood pressure, fever, chills, rashes)
  • embryofetal harm

Drug interactions

Adalimumab
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Baricitinib
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Certolizumab
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Cladribine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Deferiprone
Severe
Database

Clinical effect not specified

Source: DDInter

Etanercept
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Fingolimod
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Golimumab
Severe
Database

Clinical effect not specified

Source: DDInter

Infliximab
Severe
Database

Clinical effect not specified

Source: DDInter

Leflunomide
Severe
Database

Clinical effect not specified

Source: DDInter

Measles Virus Vaccine Live Attenuated
Severe
Database

Clinical effect not specified

Source: DDInter

Mumps Virus Strain B Level Jeryl Lynn Live Antigen
Severe
Database

Clinical effect not specified

Source: DDInter

Related guidelines

Ask House about olaratumab

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team